Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study

Autor: Streichenberger, A., Benjamin Pariente, Bozon, A., Arab, N., Amiot, A., Vuitton, L., Tilmant, M., Nachury, M., Altwegg, R., Delasalle, T., Gagniere, C., Gregoire, B., Fumery, M., Wils, P., Chambrun, G. P., Hebuterne, X., Pereira, B., Bommelaer, G., Buisson, A.

Publikováno v: Journal of Crohn's and Colitis
13. European Crohn’s and Colitis Organisation
13. European Crohn’s and Colitis Organisation, Feb 2018, Vienne, Austria
ResearcherID

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a634541bf136379091484edfce784afa
https://hal.inrae.fr/hal-02733808

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

Autor: Laharie, D, Bourreille, A, Branche, J, Allez, M, Bouhnik, Y, Filippi, J, Zerbib, F, Savoye, G, Vuitton, L, Moreau, J, Amiot, A, Cosnes, J, Ricart, E, Dewit, Olivier, Lopez-Sanroman, A, Fumery, M, Carbonnel, F, Bommelaer, G, Coffin, B, Roblin, X, van Assche, G, Esteve, M, Farkkila, M, Gisbert, J P, Marteau, P, Nahon, S, de Vos, M, Lambert, J, Mary, J Y, Louis, E, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

Publikováno v: Gut
Gut, BMJ Publishing Group, 2018, 67 (2), pp.237-243. ⟨10.1136/gutjnl-2016-313060⟩
Gut, Vol. 67, no.2, p. 237-243 (2018)

ObjectiveCiclosporin and infliximab have demonstrated short-term similar efficacy as second-line therapies in patients with acute severe UC (ASUC) refractory to intravenous steroids. The aim of this study was to assess long-term outcome of patients i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d1cfb7826291e2f23de2cdf5f026af
https://hal.uca.fr/hal-01682138

Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn's disease

Autor: Allimant, C., Messadeg, L., Quinard, R. Minet, Goutte, Marion, Bouvier, D., Goutorbe, F., Pereira, B., Bommelaer, G., Hordonneau, C., Buisson, A.

Publikováno v: Congress of ECCO-European Crohn's and Colitis Organisation
Congress of ECCO-European Crohn's and Colitis Organisation, 2018, Oxford, United Kingdom. Oxford University Press, Journal of Crohn's and Colitis, 12 Suppl 1, 2018, Congress of ECCO-European Crohn's and Colitis Organisation

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bea76fe764cda518a6135ced7c86ae74
https://hal.inrae.fr/hal-02734071

MRI remission after therapeutic intervention is associated with more time spent in clinical corticosteroids-free remission and decreased risk of surgery in Crohn's disease

Autor: Buisson, A., Hordonneau, C., Goutorbe, F., Allimant, C., Goutte, Marion, Reymond, M., Pereira, B., Bommelaer, G.

Publikováno v: 12. Congress of ECCO 2017
12. Congress of ECCO 2017, Jul 2017, Barcelone, Spain. Oxford University Press, Journal of Crohn's and Colitis, 11, 2017

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d518d1edc1b878ade7b67532b82bc0e9
https://hal.inrae.fr/hal-02734056